Expression and recovery of functional G-protein-coupled receptors using baculovirus expression systems

Current Opinion in Biotechnology

Volumn 9, Issue 5, 1998, Pages 523-527

  Bouvier, Michel ^a   Ménard, Luc ^b   Dennis, Michael ^b   Marullo, Stefano ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^c INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

BACULOVIRUS; GENE EXPRESSION SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VIRUS PARTICLE;

UNIDENTIFIED BACULOVIRUS;

EID: 0032192148     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0958-1669(98)80040-2     Document Type: Review

References (48)

1. 2-adrenergic receptors expressed in Escherichia coli membranes retain their pharmacological properties. Proc Natl Acad Sci USA. 85:1988;7551-7555.
2. Marullo S, Delavier-Klutchko C, Guillet J-G, Charbit A, Strosberg AD, Emorine LJ. Expression of human β1 and β2 adrenergic receptors in E. coli as a new tool for ligand screening. Biotechnology. 7:1989;923-927.
3. Luckow VA, Summers MD. Trends in the development of baculovirus expression vectors. Biotechnology. 6:1988;47-55.
4. Kuroda K, Geyer H, Geyer R, Doerfler W, Klenk H-D. The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. Virology. 174:1990;418-429.
5. Chazenbalk GD, Rapoport B. Expression of the extracellular domain of the thyrotropin receptor in the baculovirus system using a promoter active earlier than the polyhedrin promoter. J Biol Chem. 270:1995;1543-1549.
6. George ST, Arbabian MA, Ruoho AE, Kiely J, Malbon CC. High-efficiency expression of a mammalian β-adrenergic receptors in baculovirus-infected insect cells. Biochem Biophys Res Commun. 163:1989;1265-1269.
7. 2-adrenergic receptor in Sf9 cells. J Biol Chem. 267:1992;21733-21737.
8. Parker EM, Kameyama K, Higashijima T, Ross EM. Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J Biol Chem. 266:1991;519-527.
9. Labrecque J, Fargin A, Bouvier M, Chidiac P, Dennis M. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5HT2C receptor in Sf9 cells. Mol Pharmacol. 48:1995;150-159.
10. Nebigil CG, Garnovskaya MN, Casanas SJ, Mulheron JG, Parker EM, Gettys TW, Raymond JR. Agonist-induced desensitization and phosphorylation of human 5-HT1A receptor expressed in Sf9 insect cells. Biochemistry. 34:1995;11954-11962.
11. Butkerait P, Zheng Y, Hallak H, Graham TE, Miller H, Burris K, Molinoff PB, Manning DR. Expression of the human 5-hydroxytryptamine 1A receptor in Sf9 cells. J Biol Chem. 270:1995;18691-18699.
12. 1B receptor expression in Sf9 cells: phosphorylation, palmitoylation and adenylyl cyclase inhibition. Biochemistry. 32:1993;11727-11733.
13. Vasudevan S, Hulme EC, Bach M, Haase W, Pavia J, Reilander H. Characterization of the rat m3 muscarinic acetylcholine receptor produced in insect cells infected with recombinant baculovirus. Eur J Biochem. 227:1995;466-475.
14. Hayashi MK, Haga T. Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail. Arch Biochem Biophys. 340:1997;376-382.
15. Richardson RM, Hosey MM. Agonist-induced phosphorylation and desensitization of human m2 muscarinic cholinergic receptors in Sf9 insect cells. J Biol Chem. 267:1992;22249-22255.
16. Ng GY, Mouillac B, George S, Caron M, Dennis M, Bouvier M, O'Dowd B. Desensitization, phosphorylation and palmitoylation of the human D1 dopamin receptor. Eur J Pharmacol Mol Pharmacol Sec. 267:1994;7-19.
17. Ng GYK, O'Dowd BF, Caron M, Dennis M, Brann MR, George SR. Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells. J Neurochem. 63:1994;1589-1595.
18. Narayan P, Gray J, Puett D. Expression of functional lutropin/choriogonadotropin receptor in the baculovirus system. Mol Cell Endocrinol. 117:1996;95-100.
19. Nishimura K, Warabi K, Roush ED, Frederick J, Schwinn DA, Kwatra MM. Characterization of GRK2-catalyzed phosphorylation of the human substance P receptor in Sf9 membranes. Biochemistry. 37:1998;1192-1198.
20. Moepps B, Frodl R, Rodewald HR, Baggiolini M, Gierschik P. Two murine homologues of the human chemokine receptor CXCR4 mediating stromal cell-derived factor 1alpha activation of Gi2 are differentially expressed in vivo. Eur J Immunol. 27:1997;2102-2112.
21. Chidiac C, Hebert TE, Valiquette M, Dennis M, Bouvier M. Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol. 45:1994;490-499.
22. Chidiac P, Nouet S, Bouvier M. Agonist-induced modulation of inverse agonist efficacy at the β2-adrenergic receptor. Mol Pharmacol. 50:1996;662-669.
23. Westphal R, Sanders-Bush E. Reciprocal binding properties of 5-hydroxytryptamine type 2c receptor agonists and inverse agonists. Mol Pharmacol. 46:1994;937-942.
24. Tiberi M, Caron MG. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem. 269:1994;27925-27931.
25. Barr AJ, Brass LF, Manning DR. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. of special interest J Biol Chem. 272:1997;2223-2229 This article illustrates that co-expression of GPCRs with distinct G-protein subunits in Sf9 cells can be used to assess the receptor - G-protein coupling selectivity.
26. Clawges HM, Depree KM, Parker EM, Graber SG. Human 5-HT1 receptor subtypes exhibit distinct G protein coupling behaviors in membranes from Sf9 cells. of special interest Biochemistry. 36:1997;12930-12938 Reconstitution of G-protein subunits purified form Sf9 cells with membranes derived from Sf9 cells expressing specific GPCRs to assess the receptor - G-protein coupling selectivity. This article shows that using such in vitro reconstitution assay may offer a more quantitative assessment than using a whole cell co-expression system.
27. Benovic JI, Bouvier M, Caron MG, Lefkowitz RJ. Regulation of adenylyl cyclase-coupled β-adrenergic receptors. Annu Rev Cell Biol. 4:1988;405-427.
28. Bouvier M, Moffett S, Loisel TP, Mouillac B, Hebert T, Chidiac P. Palmitoylation of G-protein coupled receptors: a dynamic modification with functional consequences. Biochem Soc Trends. 23:1995;116-120.
29. Fredericks ZL, Pitcher JA, Lefkowitz RJ. Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor. J Biol Chem. 271:1996;13796-13803.
30. Moffett S, Adam L, Bonin H, Loisel TP, Bouvier M, Mouillac B. Palmitoylated cysteine 341 modulates phosphorylation of the β2-adrenergic receptor by cAMP-dependent protein kinase. J Biol Chem. 271:1996;21490-21497.
31. Onorato JJ, Gillis Me, Liu Y, Benovic JL, Ryoho AE. The beta-adrenergic receptor kinase (GRK2) is regulated by phospholipids. J Biol Chem. 270:1995;21346-21353.
32. Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ. Role of βgamma subunits of G proteins in targeting the β-adrenergic receptor kinase to membrane-bound receptors. Science. 257:1992;1264-1267.
33. 341 in the carboxyl tail leads to an uncoupled non-palmitoylated form of the receptor. J Biol Chem. 264:1989;7564-7569.
34. Loisel TP, Adam L, Hebert T, Bouvier M. Agonist stimulation increases the turnover rate of β2AR-bound palmitate and promotes receptor depalmitoylation. Biochemistry. 35:1996;15923-15932.
35. Bouvier M, Chidiac P, Hebert TE, Loisel TP, Moffett S, Mouillac B. Dynamic palmitoylation of G protein-coupled receptors in eukaryotic cells. Methods Enzymol. 250:1995;300-314.
36. Hayashi MK, Haga T. Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail. Arch Biochem Biophys. 340:1997;376-382.
37. 2-adrenergic receptor lacking the palmitoylated Cys341. EMBO J. 12:1993;349-356.
38. Kwatra MM, Schreurs J, Schwinn DA, Innis MA, Caron MG, Lefkowitz RJ. Immunoaffinity purification of epitope-tagged human beta-2 adrenergic receptor to homogeneity. Protein Expr Purif. 6:1995;717-721.
39. Reilander H, Boege F, Vasudevan S, Maul G, Hekman M, Dees C, Hampe W, Helmreich EJM, Michel H. Purification and functional characterization of the human beta2-adrenergic receptor produced in baculovirus-infected insect cells. FEBS. 282:1991;441-444.
40. Kobilka BK. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal Biochem. 231:1995;269-271.
41. Mazina KE, Strader CD, Tota MMR, Daniel S, Fong TM. Purification and reconstitution of a recombinant human neurokinin-1 receptor. J Recept Signal Transduct Res. 16:1996;191-207.
42. Gimpl G, Anders J, Thiele C, Fahrenholtz F. Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Eur J Biochem. 237:1996;768-777.
43. Guan X-M, Kobilka TS, Kobilka BK. Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. J Biol Chem. 267:1992;21995-21998.
44. Gether U, Lin S, Ghanouni P, Ballesteros JA, Weinstein H, Kobilka BK. Agonist induced conformational changes in transmembrane domains III and VI of the β2-adrenergic receptor. of outstanding interest EMBO J. 16:1997;6737-6747 Illustration of the use of GPCR purified to homogeneity from Sf9 cells for biophysical studies aimed at directly assessing the conformational changes occuring upon receptor activation.
45. Quehenberger O, Prossnitz ER, Cochrane CG, Ye RD. Absence of Gi proteins in the Sf9 insect cells. J Biol Chem. 267:1992;19757-19760.
46. Loisel TP, Ansanay H, St-Onge S, Gay B, Boulanger P, Strosberg AD, Marullo S, Bouvier M. Recovery of homogeneous and functional beta-2 adrenergic receptors form extracellular baculovirus particles. of outstanding interest Nat Biotechnol. 15:1997;1300-1304 The first report documenting that fully processed and functional GPCR are expressed at the surface of extracellular baculovirus particles released from baculovirus infected cells. This may offer an advantageous source of receptor for biophysical and structural studies.
47. Thomsen DR, Meyer AL, Post LE. Expression of feline leukaemia virus gp85 and Gag proteins and assembly into virus-like particles using the baculovirus expression system. J Gen Virol. 73:1992;1819-1824.
48. Garnier L, Ravallec M, Blanchard P, Chaabihi H, Bossy J-P, Dechauvelle G, Jestin A, Cerutti M. Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells. J Virol. 69:1995;4060-4068.